The Next Frontier in HIV Innovation: The Transition to No Transmission

[Available On-Demand] ・ Click video to start playback;Join chat Q&A below video
In its 40-year lifetime, the HIV epidemic has shifted from a death sentence to a manageable condition thanks to life-saving medical advances. Despite this progress, unmet needs still exist, and the scientific innovation must continue to advance. With unprecedented possibilities for scientific breakthroughs, now is the time to address the real needs of tomorrow.

During this session, experts will discuss key areas influencing the future of the HIV epidemic, including the need for meaningful biopharma innovation to address unmet needs, breakthrough R&D for today and tomorrow, and necessary community engagement and political will needed to drive public health solutions to change and stop the spread of the HIV epidemic.

With the right combination of commitment towards innovation, patient engagement, stakeholder mobilization and implementation science, we can tackle the spread of the epidemic.
Moderator
photo
Science Journalist
The San Diego Union-Tribune
Speakers
photo
Executive Vice President & Chief Patient Officer
Merck & Co, Inc.
photo
Founding Executive Director
Prevention Access Campaign
photo
Director, Joseph W. Blount Center for Health and Human Rights
Emory University
photo
Executive Director
AVAC
photo
Science Journalist
The San Diego Union-Tribune